NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Nasal Swab Objective and Statistical Evaluation (NOSE Study)

CompletedN/A

Sponsor: VA Office of Research and Development

Conditions: SARS Coronavirus 2 RT-PCR Testing

Countries: United States

Supply chain disruptions have led to shortages in test swabs which are used to collect respiratory samples. Lack of these test swabs can reduce a hospital or state's ability to test patients for COVID-19. To address this shortage, many manufacturers, hospitals and individuals have designed non-traditional 3D printed swabs for COVID-19 diagnosis that could potentially meet demands for nasal swabs. However, questions regarding the safety and effectiveness of these swabs remain. This study will provide additional, statistically supported evidence as to the safety and efficacy of novel swabs.

Eligibility overview

Sex: ALL

Age: 18 Years to —

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Symptomatic or COVID-19 positive (within the past 2 weeks)
* Has a COVID-19 positive household member
* Female and male Veterans or female and male VHA employees
* Able and willing to give informed consent

Exclusion Criteria:

* Self-reported history of frequent nosebleeds or a diagnosis of coagulopathy or any bleeding disorders
* Unsuitability for mid-turbinate or nasopharyngeal swabbing due to prior surgery
* Need for legally authorized representative for purpose of giving consent

Locations (1)

Seattle, Washington, United States